Edition:
United Kingdom

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

16.48USD
23 Feb 2018
Change (% chg)

$0.39 (+2.42%)
Prev Close
$16.09
Open
$17.24
Day's High
$18.33
Day's Low
$16.08
Volume
1,007,524
Avg. Vol
635,833
52-wk High
$25.92
52-wk Low
$8.39

Latest Key Developments (Source: Significant Developments)

Corcept Therapeutics posts Q3 earnings per share $0.11
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Corcept Therapeutics Inc :Corcept Therapeutics announces third quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update.Q3 GAAP earnings per share $0.11.Q3 revenue $42.8 million versus I/B/E/S view $42 million.Q3 earnings per share view $0.14 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $157 million to $162 million.  Full Article

BRIEF-Corcept Therapeutics Q4 GAAP Earnings Per Share $0.77

* CORCEPT THERAPEUTICS ANNOUNCES 2017 FINANCIAL RESULTS AND POSITIVE INTERIM RESULTS OF RELACORILANT PHASE 2 TRIAL